发明申请
US20190151415A1 COMPOSITIONS FOR INHIBITING FIBRIN-VLDL RECEPTOR-DEPENDENT INFLAMMATION AND METHODS OF TREATMENT
审中-公开
基本信息:
- 专利标题： COMPOSITIONS FOR INHIBITING FIBRIN-VLDL RECEPTOR-DEPENDENT INFLAMMATION AND METHODS OF TREATMENT
- 申请号：US16306824 申请日：2017-06-02
- 公开(公告)号：US20190151415A1 公开(公告)日：2019-05-23
- 发明人： Leonid V. Medved , Dudley Strickland , Sergiy Yakovlev
- 申请人： Leonid V. Medved , Dudley Strickland , Sergiy Yakovlev
- 国际申请： PCT/US17/35654 WO 20170602
- 主分类号： A61K38/17
- IPC分类号： A61K38/17 ; A61P37/06 ; A61P9/10 ; A61K38/36
摘要：
The invention provides a method of treating inflammation, comprising administering to a subject in need thereof a therapeutically effective amount of an agent that inhibits binding of fibrin to Very Low Density Lipoprotein Receptor (VLDLR) or combination of this agent with agents inhibiting binding of fibrin to VE-cahherin (vascular endothelial cadherin).
公开/授权文献:
IPC结构图谱:
| A | 人类生活必需 |
| --A61 | 医学或兽医学；卫生学 |
| ----A61K | 医用、牙科用或梳妆用的配制品 |
| ------A61K38/00 | 含肽的医药配制品 |
| --------A61K38/04 | .在完全确定的序列中最多有20个氨基酸的肽；其衍生物 |
| ----------A61K38/17 | ..来源于动物；来源于人类 |